NON-FATAL DRUG OVERDOSE AMONG PERSONS WHO INJECT DRUGS DURING FIRST TWO YEARS OF THE COVID-19 PANDEMIC IN NEW YORK CITY: PREVALENCE, RISK FACTORS

Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors

Background: We examined non-fatal drug overdoses during the COVID-19 pandemic among persons who inject drugs (PWID) in New York City (NYC).Methods: We recruited 275 PWID through respondent driven sampling and tc m350 staff outreach from Oct.2021-Sept.2022 and enrolled in a cross-sectional survey.Information was collected on demographics, drug use b

read more

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together

BackgroundNeutralizing monoclonal antibodies (mAbs) to SARS-CoV-2 are clinically efficacious when administered early, decreasing hospitalization and mortality in patients with mild or moderate COVID-19.We investigated the effects of receiving mAbs (bamlanivimab alone and bamlanivimab and etesevimab together) after SARS-CoV-2 infection on the endoge

read more

The development of carbon nanostructured biosensors for glucose detection to enhance healthcare services: a review

In this review, the forefront of biosensor development has been marked by a profound exploration of carbon nanostructured materials for the specific application of glucose detection.Moreover, this progressive line of inquiry capitalizes on the distinctive attributes of carbon nanostructured materials such as carbon nanotubes, carbon quantum dots, a

read more